HK1007556A1 - Taxane derivatives their preparation and use in oncology - Google Patents

Taxane derivatives their preparation and use in oncology

Info

Publication number
HK1007556A1
HK1007556A1 HK98106815A HK98106815A HK1007556A1 HK 1007556 A1 HK1007556 A1 HK 1007556A1 HK 98106815 A HK98106815 A HK 98106815A HK 98106815 A HK98106815 A HK 98106815A HK 1007556 A1 HK1007556 A1 HK 1007556A1
Authority
HK
Hong Kong
Prior art keywords
preparation
oncology
taxane derivatives
cyclotaxanes
new
Prior art date
Application number
HK98106815A
Other languages
English (en)
Inventor
Ezio Bombardelli
Bruno Gabetta
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1007556A1 publication Critical patent/HK1007556A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/86—Ring systems containing bridged rings containing four rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98106815A 1992-03-06 1998-06-25 Taxane derivatives their preparation and use in oncology HK1007556A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920526A IT1254515B (it) 1992-03-06 1992-03-06 Tassani di interesse oncologico, loro metodo di preparazione ed uso

Publications (1)

Publication Number Publication Date
HK1007556A1 true HK1007556A1 (en) 1999-04-16

Family

ID=11362316

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106815A HK1007556A1 (en) 1992-03-06 1998-06-25 Taxane derivatives their preparation and use in oncology

Country Status (15)

Country Link
US (1) US5250722A (fr)
EP (1) EP0559018B1 (fr)
JP (1) JPH0641010A (fr)
KR (1) KR100255524B1 (fr)
AT (1) ATE137734T1 (fr)
CA (1) CA2091002C (fr)
DE (2) DE559018T1 (fr)
DK (1) DK0559018T3 (fr)
ES (1) ES2049690T3 (fr)
FI (1) FI112208B (fr)
GR (2) GR930300141T1 (fr)
HK (1) HK1007556A1 (fr)
IT (1) IT1254515B (fr)
NO (1) NO178965C (fr)
RU (2) RU2112770C1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5475120A (en) * 1990-11-02 1995-12-12 University Of Florida Method for the isolation and purification of taxol and its natural analogues
JP2646942B2 (ja) * 1991-08-12 1997-08-27 松下電器産業株式会社 ガード体付電子部品の打抜装置および打抜方法
IT1261667B (it) * 1993-05-20 1996-05-29 Tassano ad attivita' antitumorale.
US5628978A (en) * 1994-12-23 1997-05-13 Intevep, S.A. MTW zeolite for cracking feedstock into olefins and isoparaffins
US6177456B1 (en) 1995-10-02 2001-01-23 Xechem International, Inc. Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor
US5854278A (en) * 1995-12-13 1998-12-29 Xechem International, Inc. Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
US5654448A (en) * 1995-10-02 1997-08-05 Xechem International, Inc. Isolation and purification of paclitaxel from organic matter containing paclitaxel, cephalomannine and other related taxanes
US5840748A (en) * 1995-10-02 1998-11-24 Xechem International, Inc. Dihalocephalomannine and methods of use therefor
US5807888A (en) * 1995-12-13 1998-09-15 Xechem International, Inc. Preparation of brominated paclitaxel analogues and their use as effective antitumor agents
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
JP4172726B2 (ja) * 1996-05-22 2008-10-29 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド シス―ドコサヘキサエン酸とドセタキセルとの共有複合体を含有する製剤
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
CA2385528C (fr) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions et methodes de traitement du cancer utilisant des immunoconjugues et des agents chimiotherapeutiques
EP1423107B1 (fr) * 2001-03-23 2012-05-09 Luitpold Pharmaceuticals, Inc. Conjugues d'agents pharmaceutiques et d'alcools gras
US8552054B2 (en) 2001-03-23 2013-10-08 Luitpold Pharmaceuticals, Inc. Fatty amine drug conjugates
US7201507B2 (en) 2003-12-25 2007-04-10 Ichikoh Industries, Ltd. Projector type vehicle light
JP4405279B2 (ja) 2004-02-17 2010-01-27 市光工業株式会社 プロジェクタ型車両用灯具
EP1883627B1 (fr) 2005-05-18 2018-04-18 Pharmascience Inc. Composes liants de domaine bir
NZ572836A (en) 2006-05-16 2011-12-22 Pharmascience Inc Iap bir domain binding compounds
SG10201501095WA (en) 2010-02-12 2015-04-29 Pharmascience Inc Iap bir domain binding compounds
CN105541631B (zh) * 2015-10-26 2017-09-05 云南西力生物技术股份有限公司 绣线菊阿替生素A(spiratisanin A)及其制备方法和在药物上的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380916A (en) * 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives

Also Published As

Publication number Publication date
CA2091002C (fr) 2004-06-08
NO930773L (no) 1993-09-07
NO178965B (no) 1996-04-01
ATE137734T1 (de) 1996-05-15
KR100255524B1 (ko) 2000-05-01
ES2049690T1 (es) 1994-05-01
EP0559018B1 (fr) 1996-05-08
IT1254515B (it) 1995-09-25
FI930977A (fi) 1993-09-07
RU2119485C1 (ru) 1998-09-27
CA2091002A1 (fr) 1993-09-07
GR930300141T1 (en) 1994-02-28
GR3019871T3 (en) 1996-08-31
ES2049690T3 (es) 1996-07-16
US5250722A (en) 1993-10-05
KR930019597A (ko) 1993-10-18
NO930773D0 (no) 1993-03-03
JPH0641010A (ja) 1994-02-15
FI930977A0 (fi) 1993-03-04
ITMI920526A1 (it) 1993-09-06
FI112208B (fi) 2003-11-14
DE69302508T2 (de) 1996-09-12
ITMI920526A0 (it) 1992-03-06
DK0559018T3 (da) 1996-08-19
DE69302508D1 (de) 1996-06-13
EP0559018A1 (fr) 1993-09-08
NO178965C (no) 1996-07-10
DE559018T1 (de) 1994-03-17
RU2112770C1 (ru) 1998-06-10

Similar Documents

Publication Publication Date Title
GR3019871T3 (en) Taxane derivatives, their preparation and use in oncology
PL304649A1 (en) Novel derivatives of taxane and pharmaceutical agents
IL89921A0 (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
IL113462A0 (en) Substituted pyridylpyrazoles, their preparation and pesticidal compositions containing them
PT960881E (pt) Sintese do taxol e dos seus derivados
IN170909B (fr)
RU93004649A (ru) Производные таксана, способ их получения и использование в онкологии,фармкомпозиция
GB9206244D0 (en) Cytotoxic compound from a marine sponge
EP0411733A3 (en) 11-beta-aryle-gona-4,9-dien-3-ones
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
KR950701629A (ko) 신규한 탁산 유도체, 그의 제법 및 그를 함유하는 조성물(Novel taxane derivatives, their preparation and compositions containing same)
TW255893B (fr)
GR3017349T3 (en) Tert-butyloxycarbonyl-L-tyrosyl-peptidoglycan monomer and 125 I-labelled derivative thereof, their preparation and use.
IL109958A0 (en) 14-Substituted marcfortines and derivatives useful as antiparasitic agents
ATE174911T1 (de) 1-dimethylcarbamoyl-1h-1,2,4-triazole- substituiert in stellungen 3 und 5
ATE82855T1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosidphosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080219